Author:
Ghante Minal, ,Siddheshware Pooja,Bhusari Vidhya,Sawant Sanjay,Sawant Vasundhara,Kulkarni Preeti
Abstract
For determination of eliglustat tartrate, a new, specific, simple, accurate (recovery) and precise stability indicating HPLC method has been developed and validated according to ICH Q2(R1) guidelines. The HPLC method was developed using acetonitrile: 0.1 % orthophosphoric acid 40:60 (V/V) as mobile phase, with pH of mobile phase adjusted to 3.0. The column used was HiQSil C-18 (250 mm x 4.6 mm, 5 μm) as stationary phase at a flow rate of 0.7 mL min-1. Retention time for eliglustat tartarate was found to be 5.9 min. The eluted compounds were detected using a PDA detector. The drug was subjected to stress testing as per ICH Q1A (R2) guideline. The degradation products did not interfere with the retention time of eliglustat. The calibration curve was found to be linear over a concentration range of 10-50 µg mL-1. For the calibration plots, R2 was found as 0.9995, indicating good linear relationship. The accuracy of the developed method was in the range of 99.87-100.62 %. The limit of detection of eliglustat was found to be 0.23 µg mL-1 and limit of quantification was 0.68 µg mL-1.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference5 articles.
1. 1. European Medicine Agency, Science Medicines Health 2014;1-75.
2. 2. Peterschmitt J. M., Zhang K., Liu L., Cox G. F.: Evaluation of glucosylsphingosine as a biomarker of the Eliglustat treatment response in patients with Gaucher disease type 1 (GD1), Molecular Genetics and Metabolism Journal, 2016, 117(2) S94-S95.
3. 3. Venkata K. R., Narayana S., Rajeswari R., Pinaki S. A.: Bioanalytical Method for Eliglustat Quantification in Rat Plasma, Journal of Chromatographic Science, 2017, 57(1) 600-605.
4. 4. ICH guidelines for validation of analytical procedures: text and methodology Q2(R1).
5. 5. ICH guidelines for stability testing of new drug substances and products Q1A(R2).